Syntone Ventures LLC 13D and 13G filings for Outlook Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-04 8:55 pm Purchase | 2021-02-03 | 13D | Outlook Therapeutics, Inc. OTLK | Syntone Ventures LLC | 991,152 11.700% | 191,152 (+23.89%) | Filing |
| 2020-06-12 4:17 pm Purchase | 2020-06-02 | 13D | Outlook Therapeutics, Inc. OTLK | Syntone Ventures LLC | 800,000 14.900% | 800,000 (New Position) | Filing |